Table 2.
Baseline and 10-year follow up characteristics of men and women in the Västerbotten Intervention Programme longitudinal study, 1990–2004, by weight gain or non-gain status.1
| Baseline characteristic | Men | Women | |||
| Non-gain | Gain | Non-gain | Gain | ||
| Number (%) | 2569 (36.4) | 4487 (63.6) | 2673 (34.2) | 5138 (65.8) | |
| BMI (kg/m2) | Baseline | 25.1 ± 2.4 | 24.5 ± 2.5 | 23.9 ± 2.6 | 23.5 ± 2.6 |
| 10-year follow-up | 24.9 ± 2.7 | 26.8 ± 3.1 | 23.4 ± 2.7 | 26.2 ± 3.6 | |
| Weight (kg) | Baseline | 79.7 ± 9.1 | 78.3 ± 9.3 | 65.2 ± 8.2 | 64.0 ± 8.0 |
| 10-year follow-up | 78.7 ± 9.1 | 85.6 ± 10.8 | 63.6 ± 8.1 | 71.3 ± 10.1 | |
| Civil status (%) | Single | 13.2 | 13.2 | 6.1 | 6.9 |
| Married | 81.9 | 80.9 | 85.9 | 84.1 | |
| Widowed | 0.4 | 0.4 | 1.3 | 1.2 | |
| Divorced or separated | 3.4 | 4.2 | 5.3 | 6.6 | |
| Remarried | 1.0 | 1.3 | 1.4 | 1.1 | |
| Education (%) | Low | 28.0 | 21.9 | 25.2 | 22.3 |
| Medium | 50.6 | 57.2 | 46.9 | 49.2 | |
| High | 22.3 | 18.7 | 26.1 | 27.0 | |
| Serum cholesterol, mmol/L | 5.3 ± 4.0 | 5.5 ± 1.2 | 5.5 ± 1.1 | 5.3 ± 1.1 | |
| Heart disease (%) | 4.3 | 4.0 | 2.5 | 2.0 | |
| Use of medicine for heart disease (%) | 3.3 | 3.2 | 2.5 | 2.0 | |
| Family history of CV disease (%) | 17.0 | 16.6 | 17.5 | 18.3 | |
| Hypertension (%) | 28.5 | 21.2 | 19.8 | 17.2 | |
| Snuff use (%) | 21.8 | 26.3 | 2.4 | 3.5 | |
| Glucose metabolism (%) | Normal | 95.5 | 97.5 | 93.7 | 95.2 |
| Glucose intolerance2 | 3.1 | 1.9 | 5.0 | 1.4 | |
| Diabetes type 23 | 1.4 | 0.7 | 1.3 | 0.7 | |
| Family history of diabetes (%) | 15.0 | 13.2 | 16.7 | 16.3 | |
Data are presented as mean (± SD) unless otherwise noted. 1Non-gain was defined as weight loss or maintenance of body weight within 3% of baseline weight. Gain was defined as an increase in weight of ≥3%.